The Fly报道,Alliance Global Partners在周一发布的一份报告中将Viveve Medical(纳斯达克股票代码:VIVE — 获取评级)的股票从买入评级下调至中性评级。Viveve 医疗价格表演者 kopsource2023/01/26 15:44 Viveve Medical(纳斯达克股票代码:VIVE)将联盟全球合作伙伴的评级下调至 “中立” The Fly报道,Alliance Global Partner...
Viveve Medical(VIVE.US):2022年Q3财报实现营收168.4万美元,前值为161.6万美元,预期值为170万美元,比市场预期低0.94%;每股收益为-0.59美元,前值为-0.67美元,预期值为-0.66美元,超出市场预期10.61%。 Viveve Medical(VIVE.US)公司简介:Viveve Medical Inc设计、开发、制造并营销一种平台医疗技术。它的低温冷却单极射...
VIVE: Viveve Medical, Inc. Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal ...+ VIEW MORE ...
VIVEVE MEDICAL, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share data) Note: All share and per share data has been adjusted to reflect the 1-for-10 reverse stock split which became effective after market close on December 1, 2020....
VIVE: Viveve Medical, Inc. Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal ...+ VIEW MORE ...